Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer’s disease is a research paper published in Acta Neuropathologica Communications (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F32AG072826
National Institutes of Health
Grant: P30AG072958
National Institutes of Health
Grant: P01-AG-066597
National Institutes of Health
Grant: RF1AG068063
Alzheimer's Association
Grant: AARG-22-924321
CurePSP
Grant: 656-2018-06
NIA NIH HHS
Grant: P30 AG072979
NIA NIH HHS
Grant: P01 AG066597
NIEHS NIH HHS
Grant: P30 ES010126
National Institutes of Health
Grant: 5P01AG066597-02
From cells to complex syndromes: using networks to understand heterogeneity in TDP-related frontotemporal degeneration and aging
National Institutes of Health
Grant: 5P30AG072979-02
Penn Alzheimer's Disease Research Center (ADRC)
National Institutes of Health
Grant: 1RF1AG068063-01A1
Sleep-dependent synaptic homeostasis in Alzheimer's disease
National Institutes of Health
Grant: 5F32AG072826-03
Novel Acetylated Tau Immunotherapy for Alzheimer's disease
National Institutes of Health
Grant: 1P30AG072958-01
Duke/UNC Alzheimer's Disease Research Center
FWCI
1.86
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals